LINC00920

Across TCGA pan-cancer cohorts, LINC00920 RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of LINC00920’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where LINC00920 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC00920 is over-expressed in tumor, although a few such as LUSC and UCEC show the opposite, repressed pattern.

COAD, STAD, and KIRC are the cancer types where LINC00920 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC00920 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Male	II,III,IV	+1.593	<.001	10	view →
STAD	Male	All	+0.961	<.001	9	view →
KIRC	All	All	+0.383	<.001	9	view →
LUSC	All	III,IV	−1.698	<.001	8	view →
UCEC	All	II,III,IV	−0.862	<.001	8	view →
LUAD	All	All	−0.641	<.001	7	view →
KICH	Female	All	−0.548	<.001	7	view →
BRCA	All	III,IV	−1.017	<.001	6	view →
CHOL	All	All	+1.538	.002	5	view →
KIRP	All	All	+0.431	.006	4	view →
BLCA	Female	IV	+0.779	.033	3	view →
ESCA	Female	All	+1.403	.033	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 13 lineages.

LINC00920–COAD

Open the COAD breakdown →